However, sGC stimulator BAY 41–8543 intervention had no effect on the expression of these proteins, including MMK6 and caspase-3, nor on renal interstitial fibrosis and glomerulosclerosis. This evidence concerns the gene CASP3 and glomerulosclerosis.